T

TreeFrog Therapeutics

105 employees

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
bioreactor stem cell cultivation
Therapeutics
Stem cell mass-production
Stem Cell
Cell Therapy
Biopharma
biomimetic 3D cell culture
Cell therapy cGMP manufacturing

Date founded

2018

Funding rounds raised

Total raised

$75M

from 9 investors over 9 rounds

T

TreeFrog Therapeutics raised $75M on September 13, 2021

Investors: BNP Paribas Développement, Aquitaine Science Transfert (SATT Aquitaine), XAnge, Bristol-Myers Squibb, UK and AQUITI Gestion

T

TreeFrog Therapeutics raised $3.3M on September 5, 2019

Investors: European Commission

T

TreeFrog Therapeutics raised $7.3M on May 13, 2019

Investors: AQUITI Gestion, GALIA GESTION and XAnge

FAQ